Literature DB >> 10998390

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

D J Diekema1, A B Brueggemann, G V Doern.   

Abstract

Resistance of Streptococcus pneumoniae to antimicrobial drugs is increasing. To investigate the relationship between antimicrobial use and susceptibility of S. pneumoniae isolates at 24 U.S. medical centers, we obtained data on outpatient antimicrobial-drug use for the regions surrounding 23 of these centers. We found an association between decreased penicillin susceptibility and use of beta-lactam antimicrobial drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998390      PMCID: PMC2627961          DOI: 10.3201/eid0605.000519

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  25 in total

1.  Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.

Authors:  G V Doern; M A Pfaller; K Kugler; J Freeman; R N Jones
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

Review 2.  The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals.

Authors:  R Gaynes
Journal:  Infect Dis Clin North Am       Date:  1997-12       Impact factor: 5.982

3.  Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

Authors:  R Gonzales; J F Steiner; M A Sande
Journal:  JAMA       Date:  1997-09-17       Impact factor: 56.272

4.  Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.

Authors:  D N Gerding; T A Larson
Journal:  Am J Med       Date:  1986-06-30       Impact factor: 4.965

Review 5.  Antimicrobial resistance in hospital organisms and its relation to antibiotic use.

Authors:  J E McGowan
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

6.  Pneumococcal resistance patterns in Europe.

Authors:  C Pradier; B Dunais; H Carsenti-Etesse; P Dellamonica
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

7.  Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae.

Authors:  R Muñoz; T J Coffey; M Daniels; C G Dowson; G Laible; J Casal; R Hakenbeck; M Jacobs; J M Musser; B G Spratt
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

8.  Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.

Authors:  R Pallares; F Gudiol; J Liñares; J Ariza; G Rufi; L Murgui; J Dorca; P F Viladrich
Journal:  N Engl J Med       Date:  1987-07-02       Impact factor: 91.245

9.  An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage.

Authors:  J J Muscato; D W Wilbur; J J Stout; R A Fahrlender
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

10.  Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.

Authors:  G V Doern; A B Brueggemann; H Huynh; E Wingert
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

View more
  17 in total

1.  Availability of antibiotics without prescription in New York City.

Authors:  Elaine Larson; Lorena Grullon-Figueroa
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

2.  The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy.

Authors:  D Boccia; S Spila Alegiani; A Pantosti; M L Moro; G Traversa
Journal:  Eur J Clin Pharmacol       Date:  2004-03-10       Impact factor: 2.953

3.  Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States.

Authors:  Ruth Link-Gelles; Ann Thomas; Ruth Lynfield; Sue Petit; William Schaffner; Lee Harrison; Monica M Farley; Deborah Aragon; Megin Nicols; Pam Daily Kirley; Shelley Zansky; James Jorgensen; Billie Anne Juni; Delois Jackson; Matthew R Moore; Marc Lipsitch
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

4.  Rapidly increasing prevalence of penicillin-resistant Streptococcus pneumoniae in middle Tennessee: a 10-year clinical and molecular analysis.

Authors:  Yi-Wei Tang; Haijing Li; Jane P Griffin; David W Haas; Erika M C D'Agata
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 5.  The role of antibacterial therapy of acute otitis media in promoting drug resistance.

Authors:  C E Johnson; S Belman
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

6.  An analysis of why highly similar enzymes evolve differently.

Authors:  Fahd K Majiduddin; Timothy Palzkill
Journal:  Genetics       Date:  2003-02       Impact factor: 4.562

7.  Prescribing habits of general practitioners in the treatment of childhood respiratory-tract infections.

Authors:  Ahmet Akici; Sibel Kalaça; M Umit Uğurlu; Sule Oktay
Journal:  Eur J Clin Pharmacol       Date:  2004-03-31       Impact factor: 2.953

8.  Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.

Authors:  Raymond Cha; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

9.  Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Tsu-Lan Wu; Dine Yang; Wen-Kuei Huang; Jainn-Ming Shyr; Yin-Ching Chuang; Jen-Hsien Wan; Jing-Jou Yan; Jang-Jih Lu; Jiunn-Jong Wu; Wen-Chien Ko; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Chun-Ming Lee; Hsieh-Shong Leu; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

10.  Risk factors for development of multiple-class resistance to Streptococcus pneumoniae Strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location.

Authors:  Johan Van Eldere; Robertino M Mera; Linda A Miller; James A Poupard; Heather Amrine-Madsen
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.